国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pseudoalteromonas haloplanktis D-erythrose-4-phosphate dehydrogenase (epd) CSB-YP659126PTP
CSB-EP659126PTP
CSB-BP659126PTP
CSB-MP659126PTP
CSB-EP659126PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis DNA-directed RNA polymerase subunit beta' (rpoC), partial CSB-YP659127PTP
CSB-EP659127PTP
CSB-BP659127PTP
CSB-MP659127PTP
CSB-EP659127PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Transcriptional repressor NrdR (nrdR) CSB-YP659128NAAJ
CSB-EP659128NAAJ
CSB-BP659128NAAJ
CSB-MP659128NAAJ
CSB-EP659128NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Putative ribose 1,5-bisphosphate isomerase (NP5174A) CSB-YP659129NAAJ
CSB-EP659129NAAJ
CSB-BP659129NAAJ
CSB-MP659129NAAJ
CSB-EP659129NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis UPF0753 protein NP5058A (NP5058A), partial CSB-YP659130NAAJ
CSB-EP659130NAAJ
CSB-BP659130NAAJ
CSB-MP659130NAAJ
CSB-EP659130NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Adenylate kinase (adk) CSB-YP659131NAAJ
CSB-EP659131NAAJ
CSB-BP659131NAAJ
CSB-MP659131NAAJ
CSB-EP659131NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis 50S ribosomal protein L5P (rpl5p) CSB-YP659132NAAJ
CSB-EP659132NAAJ
CSB-BP659132NAAJ
CSB-MP659132NAAJ
CSB-EP659132NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis 50S ribosomal protein L2P (rpl2p) CSB-YP659133NAAJ
CSB-EP659133NAAJ
CSB-BP659133NAAJ
CSB-MP659133NAAJ
CSB-EP659133NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Pyridoxal biosynthesis lyase pdxS (pdxS) CSB-YP659134NAAJ
CSB-EP659134NAAJ
CSB-BP659134NAAJ
CSB-MP659134NAAJ
CSB-EP659134NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis DNA-binding protein NP4416A (NP4416A) CSB-YP659135NAAJ
CSB-EP659135NAAJ
CSB-BP659135NAAJ
CSB-MP659135NAAJ
CSB-EP659135NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis 5'-nucleotidase surE (surE) CSB-YP659136NAAJ
CSB-EP659136NAAJ
CSB-BP659136NAAJ
CSB-MP659136NAAJ
CSB-EP659136NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Hydroxyethylthiazole kinase (thiM) CSB-YP659137NAAJ
CSB-EP659137NAAJ
CSB-BP659137NAAJ
CSB-MP659137NAAJ
CSB-EP659137NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Acylphosphatase (acyP) CSB-YP659138NAAJ
CSB-EP659138NAAJ
CSB-BP659138NAAJ
CSB-MP659138NAAJ
CSB-EP659138NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Probable ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP659139NAAJ
CSB-EP659139NAAJ
CSB-BP659139NAAJ
CSB-MP659139NAAJ
CSB-EP659139NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis DNA ligase (lig), partial CSB-YP659140NAAJ
CSB-EP659140NAAJ
CSB-BP659140NAAJ
CSB-MP659140NAAJ
CSB-EP659140NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Deoxyribose-phosphate aldolase (deoC) CSB-YP659141NAAJ
CSB-EP659141NAAJ
CSB-BP659141NAAJ
CSB-MP659141NAAJ
CSB-EP659141NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis 50S ribosomal protein L13P (rpl13p) CSB-YP659142NAAJ
CSB-EP659142NAAJ
CSB-BP659142NAAJ
CSB-MP659142NAAJ
CSB-EP659142NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Catalase-peroxidase (katG), partial CSB-YP659143NAAJ
CSB-EP659143NAAJ
CSB-BP659143NAAJ
CSB-MP659143NAAJ
CSB-EP659143NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Ribonuclease HII (rnhB) CSB-YP659144NAAJ
CSB-EP659144NAAJ
CSB-BP659144NAAJ
CSB-MP659144NAAJ
CSB-EP659144NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Ketol-acid reductoisomerase (ilvC) CSB-YP659145NAAJ
CSB-EP659145NAAJ
CSB-BP659145NAAJ
CSB-MP659145NAAJ
CSB-EP659145NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>